Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis, Scleroderma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06936215
What this trial is testing

Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 24
Not applicableStudy completedNCT06095921
What this trial is testing

The Effect of a Self-Management Program on Individuals With Scleroderma

Who this might be right for
SclerodermaSystemic Sclerosis
Emirhan Karakuş 29
Not applicableUnknownNCT02136394
What this trial is testing

The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis

Who this might be right for
Interstitial Lung DiseaseSystemic SclerosisGastroesophageal Reflux
Royal Brompton & Harefield NHS Foundation Trust 100
Early research (Phase 1)Study completedNCT00848939
What this trial is testing

Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
United Therapeutics 28
Not applicableStudy completedNCT00946738
What this trial is testing

The Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's PhenomenonSystemic Sclerosis
Charite University, Berlin, Germany 28
Not applicableUnknownNCT03257878
What this trial is testing

Health-related Quality of Life in Korean Patients With Rheumatic Diseases

Who this might be right for
Scleroderma, Systemic
Seoul National University Hospital 500
Not applicableStudy completedNCT02240888
What this trial is testing

Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response

Who this might be right for
RASLEVasculitis+3 more
Region Skane 300
Not applicableNot Yet RecruitingNCT06588959
What this trial is testing

6-minute Pegboard Ring Test in Patients With Scleroderma

Who this might be right for
Systemic Sclerosis (SSc)Scleroderma
Yasemin GEDIKLI 50
Not applicableStudy completedNCT04610788
What this trial is testing

Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH

Who this might be right for
SclerodermaPulmonary Artery Hypertension
Johns Hopkins University 43
Testing effectiveness (Phase 2)Ended earlyNCT01545427
What this trial is testing

Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma

Who this might be right for
Scleroderma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10
Large-scale testing (Phase 3)Study completedNCT01474109
What this trial is testing

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients

Who this might be right for
Systemic SclerosisUlcers
Actelion 289
Not applicableStudy completedNCT00697736
What this trial is testing

Cardiac Repercussion of Systemic Sclerodermias

Who this might be right for
Systemic Scleroderma
Hospices Civils de Lyon 148
Not applicableLooking for participantsNCT04804930
What this trial is testing

Trichoscopy and Systemic Scleroderma

Who this might be right for
Scleroderma, Systemic
University Hospital, Lille 200
Testing effectiveness (Phase 2)UnknownNCT02356809
What this trial is testing

Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon

Who this might be right for
Secondary Raynaud's Phenomenon
Artgen Biotech 30
Testing effectiveness (Phase 2)Study completedNCT05214794
What this trial is testing

An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Maruho Co., Ltd. 6
Not applicableUnknownNCT03819777
What this trial is testing

Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial HypertensionSystemic SclerosisSystemic Lupus
Maastricht University Medical Center 150
Large-scale testing (Phase 3)UnknownNCT00934427
What this trial is testing

Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms

Who this might be right for
Raynaud Disease
MediQuest Therapeutics 100
Early research (Phase 1)Ended earlyNCT04948554
What this trial is testing

MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)

Who this might be right for
Systemic Sclerosis With and Without Interstitial Lung Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 5
Not applicableLooking for participantsNCT06339957
What this trial is testing

Rheumatology Diet Study

Who this might be right for
Diet HabitRheumatologic DiseaseAutoimmune Diseases+8 more
University of Central Florida 500
Large-scale testing (Phase 3)UnknownNCT03856853
What this trial is testing

Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis-associated Interstitial Lung Disease (Ssc-ild)
Beijing Continent Pharmaceutical Co, Ltd. 144
Next Page